| Literature DB >> 31089378 |
Sepideh Salari1, Sedigheh Esmaeilzadeh Bahabadi1, Alireza Samzadeh-Kermani2, Forough Yosefzaei3.
Abstract
Nowadays, green synthesis of metal nanoparticles has become a promising synthetic strategy in nanotechnology and materials sciences. In this research, biosynthesis of silver nanoparticles (AgNPs) was successfully accomplished in the presence of Prosopis farcta fruit extract as a reducing agent. Proceeding of the reaction was assessed by using UV-vis spectroscopy. Characterization of silver nanoparticles was carried out by X-ray Diffraction spectroscopy (XRD) and transmission electron microscopy (TEM). The influence of process variables such as temperature, reaction time, and extract concentration was also investigated to optimize the biosynthesis of silver nanoparticles. The average size of synthesized AgNPs was 12.68 nm (10.26-14.65 nm). Furthermore, fruit extract and AgNPs were evaluated for total phenolic and flavonoid contents and were subjected to determine their antiradical scavenging activity using 1,1-diphenyl-2-picryl-hydrazyl (DPPH) and ferric reducing antioxidant power (FRAP) assay and antimicrobial activity against Staphylococcus aureus, Streptococcus pneumonia, Escherichia, Salmonella typhi using the disk diffusion method. The total phenols and flavonoids in AgNPs-containing plant extract were 462.69 (mg GAE/g extract) and 386.94 (mg QE/g extract) respectively, which were significantly higher than fruit extract. Biosynthesized AgNPs showed a higher antioxidant and antibacterial activity compared to P. farcta fruit extract alone. It could be concluded that P. farcta fruit extract can be extensively used in the production of potential antioxidant and antibacterial AgNPs for biomedical application.Entities:
Keywords: Antibacterial properties; Antioxidant activity; Prosopis farcta; Silver nanoparticles
Year: 2019 PMID: 31089378 PMCID: PMC6487442
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Antibacterial activity of synthesized AgNPs and fruit extract of P. farcta against the human pathogenic bacterial strains
|
| |||||
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
| 14.66±2.51 | - | 12±1 | 14±2. 5 | - |
|
| 18.66±2.08 | - | 11±1 | 13.33±0.58 | - |
|
| 28±2.64 | - | 13.33±3.51 | 15±2.65 | - |
|
| 29.33±3.78 | 7.66±0.57 | 15±1.73 | 17.33±0.58 | 8.5±0.5 |
Figure 1Photograph of the reduction of Ag+ to Ag in the presence of fruit extract of P. farcta during 12 h
Figure 2AUV–vis spectra of different volumes of P. farcta fruit extract with aqueous solution of 0.001M AgNO3 at three different temperatures at 25 min
Figure 2BUV–vis spectra of different volumes of P. farcta fruit extract with aqueous solution of 0.001M AgNO3 at three different temperatures at 45 min
Figure 4XRD spectra of synthesized MgO NPs using chemical method-I
Figure 5TEM image of biosynthesized silver nanoparticles
Total phenolics and flavonoid contents of synthesized AgNPs and fruit extract of P. farcta
|
|
|
|
|---|---|---|
| AgNPs | 462.69 ± 3.42 | 386.94 ± 3.24 |
| Fruit extract | 366.21 ± 3.03 | 283.33 ± 3.09 |
DPPH radical scavenging activity of P. farcta fruit extracts, AgNPs and Ascorbic acid
|
|
|
|
|
|---|---|---|---|
| 0.2 | 20.29±0.79 | ||
| 0.4 | 21.89±0.64 | ||
| Aqueous plant extract | 0.6 | 25.59±1.95 | 1.64±0.09 |
| 0.8 | 31.74±1.81 | ||
| 1 | 41.11±2.03 | ||
| 0.2 | 43.39±2.16 | ||
| 0.4 | 46.99±2.13 | ||
| Synthesized AgNPs | 0.6 | 52.69±3.84 | 0.70±0.08 |
| 0.8 | 55.89±2.26 | ||
| 1 | 63.56±2.41 | ||
| 0.2 | 50.79±1.08 | ||
| 0.4 | 61.89±0.60 | ||
| Ascorbic acid (Standard) | 0.6 | 64.29±0.30 | 0.26±0.09 |
| 0.8 | 66.99±0.30 | ||
| 1 | 74.49±1.20 |
[Data are presented as mean ± SD (P < 0.05). IC50: Concentration of the aqueous extract and synthesized nanoparticles causing 50% DPPH radical scavenging ability].
Figure 6FRAP antioxidant activity of synthesized AgNPs and crude fruit extract of P. farcta. Gentamicin (10μg/mL) was used as a positive control. Each value represents the mean ± standard error of three replicates per treatment
Figure 7Antibacterial activity of biosynthesized Ag-NPs against human pathogens. Antibacterial effects of biosynthesized Ag-NPs evaluated by the disk diffusion method in petri plates